Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Suppression of Foxo3-Gatm by miR-132-3p Accelerates Cyst Formation by Up-Regulating ROS in Autosomal Dominant Polycystic Kidney Disease

  • Choi, Seonju (Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University) ;
  • Kim, Do Yeon (Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University) ;
  • Ahn, Yejin (Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University) ;
  • Lee, Eun Ji (Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University) ;
  • Park, Jong Hoon (Department of Biological Sciences and Research Institute of Women's Health, Sookmyung Women's University)
  • Received : 2020.11.03
  • Accepted : 2020.11.25
  • Published : 2021.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Accumulation of reactive oxygen species (ROS) is associated with the development of various diseases. However, the molecular mechanisms underlying oxidative stress that lead to such diseases like autosomal dominant polycystic kidney disease (ADPKD) remain unclear. Here, we observed that oxidative stress markers were increased in Pkd1f/f:HoxB7-Cre mice. Forkhead transcription factors of the O class (FOXOs) are known key regulators of the oxidative stress response, which have been observed with the expression of FoxO3a in an ADPKD mouse model in the present study. An integrated analysis of two datasets for differentially expressed miRNA, such as miRNA sequencing analysis of Pkd1 conditional knockout mice and microarray analysis of samples from ADPKD patients, showed that miR-132-3p was a key regulator of FOXO3a in ADPKD. miR-132-3p was significantly upregulated in ADPKD which directly targeted FOXO3 in both mouse and human cell lines. Interestingly, the mitochondrial gene Gatm was downregulated in ADPKD which led to a decreased inhibition of Foxo3. Overexpression of miR-132-3p coupled with knockdown of Foxo3 and Gatm increased ROS and accelerated cyst formation in 3D culture. This study reveals a novel mechanism involving miR-132-3p, Foxo3, and Gatm that is associated with the oxidative stress that occurs during cystogenesis in ADPKD.

Keywords

References

  1. Andries, A., Daenen, K., Jouret, F., Bammens, B., Mekahli, D. and Van Schepdael, A. (2019) Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression? Pediatr. Nephrol. 34, 993-1008. https://doi.org/10.1007/s00467-018-4004-5
  2. Bijkerk, R., de Bruin, R. G., van Solingen, C., van Gils, J. M., Duijs, J. M., van der Veer, E. P., Rabelink, T. J., Humphreys, B. D. and van Zonneveld, A. J. (2016) Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation. Kidney Int. 89, 1268-1280. https://doi.org/10.1016/j.kint.2016.01.029
  3. Calnan, D. R. and Brunet, A. (2008) The FoxO code. Oncogene 27, 2276-2288. https://doi.org/10.1038/onc.2008.21
  4. Calvo, S. E., Clauser, K. R. and Mootha, V. K. (2016) MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 44, D1251-D1257. https://doi.org/10.1093/nar/gkv1003
  5. Ferber, E. C., Peck, B., Delpuech, O., Bell, G. P., East, P. and Schulze, A. (2012) FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 19, 968-979. https://doi.org/10.1038/cdd.2011.179
  6. Fujiki, T., Ando, F., Murakami, K., Isobe, K., Mori, T., Susa, K., Nomura, N., Sohara, E., Rai, T. and Uchida, S. (2019) Tolvaptan activates the Nrf2/HO-1 antioxidant pathway through PERK phosphorylation. Sci. Rep. 9, 9245. https://doi.org/10.1038/s41598-019-45539-8
  7. Gansevoort, R. T., Arici, M., Benzing, T., Birn, H., Capasso, G., Covic, A., Devuyst, O., Drechsler, C., Eckardt, K. U., Emma, F., Knebelmann, B., Le Meur, Y., Massy, Z. A., Ong, A. C., Ortiz, A., Schaefer, F., Torra, R., Vanholder, R., Wiecek, A., Zoccali, C. and Van Biesen, W. (2016) Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol. Dial. Transplant. 31, 337-348. https://doi.org/10.1093/ndt/gfv456
  8. Hagenbuchner, J., Kuznetsov, A., Hermann, M., Hausott, B., Obexer, P. and Ausserlechner, M. J. (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J. Cell Sci. 125, 1191-1203. https://doi.org/10.1242/jcs.092098
  9. Ham, H. J., Park, J. W. and Bae, Y. S. (2019) Defect of SIRT1-FoxO3a axis is associated with the production of reactive oxygen species during protein kinase CK2 downregulation-mediated cellular senescence and nematode aging. BMB Rep. 52, 265-270. https://doi.org/10.5483/BMBRep.2019.52.4.156
  10. Humm, A., Fritsche, E., Steinbacher, S. and Huber, R. (1997) Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. EMBO J. 16, 3373-3385. https://doi.org/10.1093/emboj/16.12.3373
  11. Igarashi, P. and Somlo, S. (2007) Polycystic kidney disease. J. Am. Soc. Nephrol. 18, 1371-1373. https://doi.org/10.1681/asn.2007030299
  12. Ishimoto, Y., Inagi, R., Yoshihara, D., Kugita, M., Nagao, S., Shimizu, A., Takeda, N., Wake, M., Honda, K., Zhou, J. and Nangaku, M. (2017) Mitochondrial abnormality facilitates cyst formation in autosomal dominant polycystic kidney disease. Mol. Cell. Biol. 37, e00337-17.
  13. Kim, D. Y., Woo, Y. M., Lee, S., Oh, S., Shin, Y., Shin, J. O., Park, E. Y., Ko, J. Y., Lee, E. J., Bok, J., Yoo, K. H. and Park, J. H. (2019) Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease. FASEB J. 33, 2870-2884.. https://doi.org/10.1096/fj.201800563RR
  14. Kim, J. E., Hong, J. W., Lee, H. S., Kim, W., Lim, J., Cho, Y. S. and Kwon, H. J. (2018) Hsa-miR-10a-5p downregulation in mutant UQCRB-expressing cells promotes the cholesterol biosynthesis pathway. Sci. Rep. 8, 12407. https://doi.org/10.1038/s41598-018-30530-6
  15. Klotz, L. O., Sanchez-Ramos, C., Prieto-Arroyo, I., Urbanek, P., Steinbrenner, H. and Monsalve, M. (2015) Redox regulation of FoxO transcription factors. Redox Biol. 6, 51-72. https://doi.org/10.1016/j.redox.2015.06.019
  16. Kops, G. J., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W., Coffer, P. J., Huang, T. T., Bos, J. L., Medema, R. H. and Burgering, B. M. (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321. https://doi.org/10.1038/nature01036
  17. Li, L., Kang, H., Zhang, Q., D'Agati, V. D., Al-Awqati, Q. and Lin, F. (2019) FoxO3 activation in hypoxic tubules prevents chronic kidney disease. J. Clin. Invest. 129, 2374-2389. https://doi.org/10.1172/JCI122256
  18. Li, Y., Li, J., Woo, Y. M., Shen, Z., Yao, H., Cai, Y., Lin, M. C. and Poon, W. S. (2017) Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model. BMC Cancer 17, 126. https://doi.org/10.1186/s12885-017-3125-8
  19. Lin, F. (2020) Molecular regulation and function of FoxO3 in chronic kidney disease. Curr. Opin. Nephrol. Hypertens 29, 439-445. https://doi.org/10.1097/MNH.0000000000000616
  20. Liu, J. W., Chandra, D., Rudd, M. D., Butler, A. P., Pallotta, V., Brown, D., Coffer, P. J. and Tang, D. G. (2005) Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene 24, 2020-2031. https://doi.org/10.1038/sj.onc.1208385
  21. Marinkovic, D., Zhang, X., Yalcin, S., Luciano, J. P., Brugnara, C., Huber, T. and Ghaffari, S. (2007) Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J. Clin. Invest. 117, 2133-2144. https://doi.org/10.1172/JCI31807
  22. Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S.L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., Kimberling, W. J., Breuning, M. H., Deltas, C. C., Peters, D. J. and Somlo, S. (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272, 1339-1342. https://doi.org/10.1126/science.272.5266.1339
  23. Peters, D. J. and Sandkuijl, L. A. (1992) Genetic heterogeneity of poly-cystic kidney disease in Europe. Contrib. Nephrol. 97, 128-139. https://doi.org/10.1159/000421651
  24. Reichold, M., Klootwijk, E. D., Reinders, J., Otto, E. A., Milani, M., Broeker, C., Laing, C., Wiesner, J., Devi, S., Zhou, W., Schmitt, R., Tegtmeier, I., Sterner, C., Doellerer, H., Renner, K., Oefner, P. J., Dettmer, K., Simbuerger, J. M., Witzgall, R., Stanescu, H. C., Dumitriu, S., Iancu, D., Patel, V., Mozere, M., Tekman, M., Jaureguiberry, G., Issler, N., Kesselheim, A., Walsh, S. B., Gale, D. P., Howie, A. J., Martins, J. R., Hall, A. M., Kasgharian, M., O'Brien, K., Ferreira, C. R., Atwal, P. S., Jain, M., Hammers, A., Charles-Edwards, G., Choe, C. U., Isbrandt, D., Cebrian-Serrano, A., Davies, B., Sandford, R. N., Pugh, C., Konecki, D. S., Povey, S., Bockenhauer, D., Lichter-Konecki, U., Gahl, W. A., Unwin, R. J., Warth, R. and Kleta, R. (2018) Glycine amidinotransferase (GATM), renal fanconi syndrome, and kidney failure. J. Am. Soc. Nephrol. 29, 1849-1858. https://doi.org/10.1681/ASN.2017111179
  25. Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Grantham, J. J., Higashihara, E., Perrone, R. D., Krasa, H. B., Ouyang, J. and Czerwiec, F. S.; TEMPO 3:4 Trial Investigators (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407-2418. https://doi.org/10.1056/NEJMoa1205511
  26. Tzivion, G., Dobson, M. and Ramakrishnan, G. (2011) FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim. Biophys. Acta 1813, 1938-1945. https://doi.org/10.1016/j.bbamcr.2011.06.002
  27. van der Horst, A. and Burgering, B. M. (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8, 440-450. https://doi.org/10.1038/nrm2190
  28. Woo, Y. M., Bae, J. B., Oh, Y. H., Lee, Y. G., Lee, M. J., Park, E. Y., Choi, J. K., Lee, S., Shin, Y., Lyu, J., Jung, H. Y., Lee, Y. S., Hwang, Y. H., Kim, Y. J. and Park, J. H. (2014) Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development. Hum. Genet. 133, 281-297. https://doi.org/10.1007/s00439-013-1378-0
  29. Woo, Y. M., Kim, D. Y., Koo, N. J., Kim, Y. M., Lee, S., Ko, J. Y., Shin, Y., Kim, B. H., Mun, H., Choi, S., Lee, E. J., Shin, J. O., Park, E. Y., Bok, J. and Park, J. H. (2017) Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models. Sci. Rep. 7, 14151. https://doi.org/10.1038/s41598-017-14083-8
  30. Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y. and Dong, W. (2016) ROS and ROS-mediated cellular signaling. Oxid. Med. Cell. Longev. 2016, 4350965. https://doi.org/10.1155/2016/4350965